Skip to main content
. 2021 Jun 16;12(1):467–482. doi: 10.1016/j.apsb.2021.05.012

Figure 9.

Figure 9

Immune cells of 4T1 tumor-bearing mice after treatment. Flow Cytometer detection and the percentages of (A) CD11c+ CD86+ cells in spleens, (B) CD11c+ CD80+ cells in spleens, (C) CD8+ IFN-γ+ cells in tumors, (D) CD4+ cells in tumors, (E) CD4+ Foxp3+ cells in tumors, (F) CD11b+ Ly6G+ cells in lungs, and (G) CD11b+ Ly6G+ cells in livers. Data are presented as mean ± SD (n = 3), ∗∗∗P < 0.001.